Shares of Avantor (NYSE:AVTR) rose 3.64% in after-market trading after the company reported Q2 results.
Earnings per share were up 35.71% year over year to $0.19, which beat the estimate of $0.14.
Revenue of $1,479,000,000 declined by 3.46% year over year, which beat the estimate of $1,450,000,000.
Earnings guidance hasn't been issued by the company for now.
Avantor hasn't issued any revenue guidance for the time being.
How To Listen To The Conference Call
Date: Jul 29, 2020
Time: 05:00 PM
ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fir.avantorsciences.com%2Finvestors%2Fevents-and-presentations%2Fdefault.aspx&eventid=2399364&sessionid=1&key=BC38D321EB28CBD6C8C92019E8DB7967®Tag=&sourcepage=register
Company's 52-week high was at $19.75
Company's 52-week low was at $6.66
Price action over last quarter: Up 17.67%
Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.